$GRDN
Guardian Pharmacy Services Inc

2024 Q3 Form 10-Q Financial Statement

#000119312524256069 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2023 Q4
Revenue $314.4M $248.9M $1.046B
YoY Change 19.66%
Cost Of Revenue $253.5M $197.7M $837.9M
YoY Change 20.41%
Gross Profit $60.88M $51.22M $208.3M
YoY Change 16.64%
Gross Profit Margin 19.36% 20.57% 19.91%
Selling, General & Admin $165.5M $44.76M $167.4M
YoY Change 182.78%
% of Gross Profit 271.84% 87.39% 80.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.352M
YoY Change
% of Gross Profit 4.49%
Operating Expenses $165.5M $44.76M $167.4M
YoY Change 182.78%
Operating Profit -$104.6M $6.457M $40.95M
YoY Change 1552.65%
Interest Expense -$702.0K -$2.859M
YoY Change
% of Operating Profit -10.87% -6.98%
Other Income/Expense, Net -$1.028M -$41.00K -$367.0K
YoY Change 54.59%
Pretax Income -$105.6M $5.714M $37.72M
YoY Change 1410.24%
Income Tax $176.0K
% Of Pretax Income
Net Earnings -$122.0M $7.095M $23.90M
YoY Change 1643.96%
Net Earnings / Revenue -38.8% 2.85% 2.28%
Basic Earnings Per Share
Diluted Earnings Per Share $0.03 $0.38
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $752.0K
YoY Change
Cash & Equivalents $37.22M $752.0K
Short-Term Investments
Other Short-Term Assets $6.885M $14.86M
YoY Change
Inventory $45.22M $36.73M
Prepaid Expenses
Receivables $90.94M $77.26M
Other Receivables $0.00
Total Short-Term Assets $180.3M $129.6M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $48.13M $45.06M
YoY Change
Goodwill $68.42M $56.05M
YoY Change
Intangibles $15.15M $11.98M
YoY Change
Long-Term Investments
YoY Change
Other Assets $374.0K $358.0K
YoY Change
Total Long-Term Assets $167.8M $141.6M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $180.3M $129.6M
Total Long-Term Assets $167.8M $141.6M
Total Assets $348.0M $271.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $106.9M $85.60M
YoY Change
Accrued Expenses $23.19M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $9.000M
YoY Change
Long-Term Debt Due $3.977M
YoY Change
Total Short-Term Liabilities $158.3M $138.0M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $28.67M $18.99M
YoY Change
Other Long-Term Liabilities $3.307M $31.50M
YoY Change
Total Long-Term Liabilities $31.97M $50.49M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $158.3M $138.0M
Total Long-Term Liabilities $31.97M $50.49M
Total Liabilities $214.1M $211.3M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $5.181M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.21M
YoY Change
Total Liabilities & Shareholders Equity $348.0M $271.2M
YoY Change

Cashflow Statement

Concept 2024 Q3 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$122.0M $7.095M $23.90M
YoY Change 1643.96%
Depreciation, Depletion And Amortization $9.352M
YoY Change
Cash From Operating Activities $29.08M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $7.031M
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$6.974M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.21M
YoY Change
NET CHANGE
Cash From Operating Activities 29.08M
Cash From Investing Activities -6.974M
Cash From Financing Activities -19.21M
Net Change In Cash 2.903M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $29.08M
Capital Expenditures $7.031M
Free Cash Flow $22.05M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001802255
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-42284
dei Entity Registrant Name
EntityRegistrantName
Guardian Pharmacy Services, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3627139
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Galleria Parkway SE
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
dei City Area Code
CityAreaCode
404
dei Local Phone Number
LocalPhoneNumber
810-0089
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GRDN
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
grdn Conversion Of Stocks Period
ConversionOfStocksPeriod
P2Y
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
752000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37221000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
77262000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90943000
CY2023Q4 us-gaap Inventory Net
InventoryNet
36727000
CY2024Q3 us-gaap Inventory Net
InventoryNet
45216000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
14864000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
6885000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
129605000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
180265000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45064000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48125000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11979000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15151000
CY2023Q4 us-gaap Goodwill
Goodwill
56046000
CY2024Q3 us-gaap Goodwill
Goodwill
68419000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28113000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29720000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5973000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
358000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
374000
CY2023Q4 us-gaap Assets
Assets
271165000
CY2024Q3 us-gaap Assets
Assets
348027000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
85603000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
106870000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16961000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13955000
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9000000
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10000000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3977000
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
5434000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6229000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6963000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16245000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15096000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
138015000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
158318000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
18992000
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
28666000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22803000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23840000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31496000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3307000
CY2023Q4 us-gaap Liabilities
Liabilities
211306000
CY2024Q3 us-gaap Liabilities
Liabilities
214131000
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Members Equity
MembersEquity
28209000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
122323000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5181000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
31650000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
6329000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59859000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
133896000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
271165000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348027000
CY2023Q3 us-gaap Revenues
Revenues
262741000
CY2024Q3 us-gaap Revenues
Revenues
314393000
us-gaap Revenues
Revenues
765126000
us-gaap Revenues
Revenues
889840000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
210549000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
253515000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
611394000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
712573000
CY2023Q3 us-gaap Gross Profit
GrossProfit
52192000
CY2024Q3 us-gaap Gross Profit
GrossProfit
60878000
us-gaap Gross Profit
GrossProfit
153732000
us-gaap Gross Profit
GrossProfit
177267000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58522000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
165491000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
128310000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
256942000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6330000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-104613000
us-gaap Operating Income Loss
OperatingIncomeLoss
25422000
us-gaap Operating Income Loss
OperatingIncomeLoss
-79675000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
716000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1026000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2120000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2857000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-141000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-166000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-665000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1028000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2261000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3023000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6995000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-105641000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23161000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82698000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
176000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
176000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-6995000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-105817000
us-gaap Profit Loss
ProfitLoss
23161000
us-gaap Profit Loss
ProfitLoss
-82874000
CY2023Q3 grdn Net Income Loss Attributable To Llc Prior To Cooperate Reorganization
NetIncomeLossAttributableToLlcPriorToCooperateReorganization
-11290000
CY2024Q3 grdn Net Income Loss Attributable To Llc Prior To Cooperate Reorganization
NetIncomeLossAttributableToLlcPriorToCooperateReorganization
9350000
grdn Net Income Loss Attributable To Llc Prior To Cooperate Reorganization
NetIncomeLossAttributableToLlcPriorToCooperateReorganization
11884000
grdn Net Income Loss Attributable To Llc Prior To Cooperate Reorganization
NetIncomeLossAttributableToLlcPriorToCooperateReorganization
22760000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4295000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6823000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11277000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16356000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121990000
us-gaap Net Income Loss
NetIncomeLoss
-121990000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59859000
CY2024Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
428000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
7095000
CY2024Q1 grdn Share Distribution Value
ShareDistributionValue
-10809000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
56573000
CY2024Q2 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
724000
CY2024Q2 us-gaap Noncash Contribution Expense
NoncashContributionExpense
4989000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
15848000
CY2024Q2 grdn Share Distribution Value
ShareDistributionValue
-20921000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57213000
CY2024Q3 grdn Net Income Prior To Corporate Reorganization Value
NetIncomePriorToCorporateReorganizationValue
16167000
CY2024Q3 grdn Share Contribution Prior To Corporate Reorganisation Value
ShareContributionPriorToCorporateReorganisationValue
955000
CY2024Q3 grdn Share Distribution Prior To Corporate Reorganization Value
ShareDistributionPriorToCorporateReorganizationValue
-18599000
CY2024Q3 grdn Conversion Of Restricted Interest Unit Awards Into Guardian Pharmacy Llc Common Units
ConversionOfRestrictedInterestUnitAwardsIntoGuardianPharmacyLlcCommonUnits
142498000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
106737000
grdn Payment To Common Stock Per Share
PaymentToCommonStockPerShare
1.02
CY2024Q3 grdn Payment To Common Stock Shareholder
PaymentToCommonStockShareholder
-55176000
CY2024Q3 grdn Recognition Of Deferred Tax Asset Net From Corporate Reorganization
RecognitionOfDeferredTaxAssetNetFromCorporateReorganization
5973000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121990000
CY2024Q3 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
6000
CY2024Q3 grdn Employee Benefits And Share Based Compensation Subsequent To Corporate Reorganization
EmployeeBenefitsAndShareBasedCompensationSubsequentToCorporateReorganization
112000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
133896000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
75929000
CY2023Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
195000
CY2023Q1 us-gaap Noncash Contribution Expense
NoncashContributionExpense
225000
CY2023Q1 grdn Net Income Prior To Corporate Reorganization Value
NetIncomePriorToCorporateReorganizationValue
5714000
CY2023Q1 grdn Share Distribution Value
ShareDistributionValue
-9346000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
72717000
CY2023Q2 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
120000
CY2023Q2 grdn Net Income Prior To Corporate Reorganization Value
NetIncomePriorToCorporateReorganizationValue
24442000
CY2023Q2 grdn Share Distribution Value
ShareDistributionValue
-20500000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
76779000
CY2023Q3 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
223000
CY2023Q3 grdn Net Income Prior To Corporate Reorganization Value
NetIncomePriorToCorporateReorganizationValue
-6995000
CY2023Q3 grdn Share Distribution Value
ShareDistributionValue
-10308000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59699000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
23161000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-82874000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13520000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14619000
us-gaap Share Based Compensation
ShareBasedCompensation
16632000
us-gaap Share Based Compensation
ShareBasedCompensation
128029000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3707000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4240000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-257000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11958000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17285000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3571000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6226000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2173000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-768000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10213000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14158000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2396000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3373000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1731000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-16402000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56265000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35623000
grdn Purchases Of Property And Equipment
PurchasesOfPropertyAndEquipment
11793000
grdn Purchases Of Property And Equipment
PurchasesOfPropertyAndEquipment
11867000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
985000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12460000
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
484000
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
544000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12294000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23783000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
119784000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
538000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55176000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
15000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3750000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
198000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
189300000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
196000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
188300000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3091000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3309000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
538000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2107000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
11732000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
14279000
grdn Payments To Member Distributions
PaymentsToMemberDistributions
28422000
grdn Payments To Member Distributions
PaymentsToMemberDistributions
36050000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
250000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
160000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43957000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24629000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36469000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
607000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
752000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
621000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37221000
us-gaap Interest Paid Net
InterestPaidNet
2082000
us-gaap Interest Paid Net
InterestPaidNet
2851000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
5562000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
2256000
grdn Accrued And Capitalized Offering Costs Recorded To Additionalpaid Incapital
AccruedAndCapitalizedOfferingCostsRecordedToAdditionalpaidIncapital
12509000
grdn Non Cashequity Contributions Fromnon Controllingmembers
NonCashequityContributionsFromnonControllingmembers
225000
grdn Non Cashequity Contributions Fromnon Controllingmembers
NonCashequityContributionsFromnonControllingmembers
4989000
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
54094232
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
one-for-one
us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
55176000
us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
55176000
grdn Adjustment Of Deferred Tax Asset Liability Through Additional Paid In Capital
AdjustmentOfDeferredTaxAssetLiabilityThroughAdditionalPaidInCapital
5973000
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
14
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119784000
CY2024Q3 grdn Payment Of Underwriting Discounts
PaymentOfUnderwritingDiscounts
9016000
CY2024Q3 grdn Addition Of Underwriting Discounts Incurred Of Offering Costs
AdditionOfUnderwritingDiscountsIncurredOfOfferingCosts
13047000
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
23000000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
34250000
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
31000
CY2024Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
151000
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
22969000
CY2024Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
34099000
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
3977000
CY2024Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
5434000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18992000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28665000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1375000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5500000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5500000
CY2024Q3 us-gaap Long Term Debt Maturing In Years Two And Three
LongTermDebtMaturingInYearsTwoAndThree
21875000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
34250000
CY2023Q3 us-gaap Legal Fees
LegalFees
314000
CY2024Q3 us-gaap Legal Fees
LegalFees
687000
us-gaap Legal Fees
LegalFees
1457000
us-gaap Legal Fees
LegalFees
4745000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-105817000
us-gaap Profit Loss
ProfitLoss
-82874000
CY2024Q3 grdn Net Income Loss Attributable To Llc Prior To Cooperate Reorganization
NetIncomeLossAttributableToLlcPriorToCooperateReorganization
9350000
grdn Net Income Loss Attributable To Llc Prior To Cooperate Reorganization
NetIncomeLossAttributableToLlcPriorToCooperateReorganization
22760000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6823000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16356000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121990000
us-gaap Net Income Loss
NetIncomeLoss
-121990000
CY2023Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
15210000
CY2024Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.043
CY2024Q3 us-gaap Share Price
SharePrice
14
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
13663000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 grdn Incremental Sharebased Compensation Upon Modification
IncrementalSharebasedCompensationUponModification
122355000
us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
55176000
grdn Adjustment Of Deferred Tax Asset Liability Through Additional Paid In Capital
AdjustmentOfDeferredTaxAssetLiabilityThroughAdditionalPaidInCapital
5973000
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001193125-24-256069-index-headers.html Edgar Link pending
0001193125-24-256069-index.html Edgar Link pending
0001193125-24-256069.txt Edgar Link pending
0001193125-24-256069-xbrl.zip Edgar Link pending
d894273d10q.htm Edgar Link pending
d894273dex105.htm Edgar Link pending
d894273dex311.htm Edgar Link pending
d894273dex312.htm Edgar Link pending
d894273dex321.htm Edgar Link pending
d894273dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grdn-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
grdn-20240930_cal.xml Edgar Link unprocessable
grdn-20240930_def.xml Edgar Link unprocessable
grdn-20240930_lab.xml Edgar Link unprocessable
grdn-20240930_pre.xml Edgar Link unprocessable
d894273d10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable